BALAXI

Balaxi Pharmaceuticals Share PriceBalaxi Pharmaceuticals

₹540.00
8.4 (1.58%)
As on 29 March, 2023 | 15:29 BSE: NSE: BALAXI

Balaxi Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Balaxi Pharmaceuticals

Start SIP

Balaxi Pharmaceuticals Share Price

  • Over 1 Month -1.57%
  • Over 3 Month -8.75%
  • Over 6 Month -13.57%
  • Over 1 Year 39.38%

Balaxi Pharmaceuticals Key Statistics

P/E Ratio 10.7
PEG Ratio 0.6
Market Cap Cr 550
Price to Book Ratio 4.9
EPS 14.4
Dividend 0
Relative Strength Index 46.32
Money Flow Index 45.84
MACD Signal -0.61
Average True Range 23.93

Balaxi Pharmaceuticals Investment Rating

  • Master Rating:
  • Balaxi Pharmaceuticals has an operating revenue of Rs. 344.85 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 20% is great, ROE of 42% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 83 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Balaxi Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 23282621
Operating Expenses Qtr Cr 20252217
Operating Profit Qtr Cr 4444
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 1211
Net Profit Qtr Cr 4454

Balaxi Pharmaceuticals Technicals

EMA & SMA

Current Price
₹540.
8.4 (1.58%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 539.97
  • 50 Day
  • 546.16
  • 100 Day
  • 550.48
  • 200 Day
  • 538.56
  • 20 Day
  • 541.11
  • 50 Day
  • 541.17
  • 100 Day
  • 566.37
  • 200 Day
  • 529.45

Balaxi Pharmaceuticals Resistance and Support

PIVOT
₹526.94
Resistance
First Resistance 543.77
Second Resistance 555.94
Third Resistance 572.77
RSI 46.32
MFI 45.84
MACD Single Line -0.61
MACD -1.01
Support
First Resistance 514.77
Second Resistance 497.94
Third Resistance 485.77

Balaxi Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,571 297,714 83.37
Week 3,171 256,430 80.88
1 Month 2,196 159,675 72.7
6 Month 3,062 221,507 72.35

Balaxi Pharmaceuticals Result Highlights

Balaxi Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Balaxi Pharmaceutica is involved in the business activities of Other specialized wholesale. Company’s Total Operating Revenue is Rs. 101.29 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2022. Balaxi Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1942 and has its registered office in the State of Kerala, India. Company’s Corporate Identification Number(CIN) is L25191TG1942PLC121598 and registration number is 000045.
Market Cap 540
Sales 98
Shares in Float 0.27
No of funds 4
Yield
Book Value 9.18
U/D Vol ratio 0.9
LTDebt / Equity
Alpha 0.16
Beta 0.84

Balaxi Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 72.69%72.86%72.86%
Foreign Portfolio Investors 18.96%19%19%
Financial Institutions/ Banks 0.03%0.03%0.03%
Individual Investors 5.11%5%
Others 3.21%3.11%8.11%

Balaxi Pharmaceuticals Management

Name Designation
Mr. Ashish Maheshwari Managing Director
Mrs. Minoshi Maheshwari Non Executive Director
Mr. M Srinivas Rao Independent Director
Mr. Purnima Singh Kamble Independent Director
Mr. Kunal M Bhakta Independent Director
Mr. Gandhi Gamji Independent Director

Balaxi Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Balaxi Pharmaceuticals FAQs

What is Share Price of Balaxi Pharmaceuticals ?

Balaxi Pharmaceuticals share price is ₹540 As on 29 March, 2023 | 15:15

What is the Market Cap of Balaxi Pharmaceuticals ?

The Market Cap of Balaxi Pharmaceuticals is ₹549.8 Cr As on 29 March, 2023 | 15:15

What is the P/E ratio of Balaxi Pharmaceuticals ?

The P/E ratio of Balaxi Pharmaceuticals is 10.7 As on 29 March, 2023 | 15:15

What is the PB ratio of Balaxi Pharmaceuticals ?

The PB ratio of Balaxi Pharmaceuticals is 4.9 As on 29 March, 2023 | 15:15

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number